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Summary
Polycomb group protein Ezh2, one of the key regula-
tors of development in organisms from flies to mice,
exerts its epigenetic function through regulation of
histone methylation. Here, we report the existence of
the cytosolic Ezh2-containing methyltransferase com-
plex and tie the function of this complex to regulation
of actin polymerization in various cell types. Genetic
evidence supports the essential role of cytosolic
Ezh2 in actin polymerization-dependent processes
such as antigen receptor signaling in T cells and
PDGF-induced dorsal circular ruffle formation in fi-
broblasts. Revealed function of Ezh2 points to a
broader usage of lysine methylation in regulation of
both nuclear and extra-nuclear signaling processes.
Introduction
Proliferation, differentiation, and metabolic activity of
eukaryotic cells are regulated by environmental signals
wired to the nucleus via protein signal transduction net-
works (Downward, 2001; Kane et al., 2000). The func-
tion of these networks is regulated by signal-induced
posttranslational protein modifications which contrib-
ute to the catalytic activity of signaling molecules as
well as to their ability to interact (Pawson, 2004). The
protein-protein interactions lead to assembly of signal-
ing complexes that transmit the external signal to the
nucleus. The posttranslational modifications of his-
tones and nonhistone proteins in the nucleus control
gene transcription that contributes to cellular responses*Correspondence: sui@mail.rockefeller.edu (I.S.); tarakho@mail.
rockefeller.edu (A.T.)(Cheung et al., 2000; Downward, 2001; Pawson, 2004;
Schreiber and Bernstein, 2002).
Among various posttranslational protein modifica-
tions, the role of protein methylation in signal transduc-
tion has not been extensively explored. Eukaryotic pro-
teins are methylated on the C-terminal carboxy group
or on the side chain nitrogens of the amino acids lysine
or arginine (Bannister et al., 2002). While the carboxy
group and arginine methylation have been implicated in
several cellular responses, including receptor signaling,
protein transport, and transcription (McBride and Silver,
2001), lysine methylation has generally been assumed
to be histone specific (Lachner and Jenuwein, 2002).
The recently discovered lysine methylation of p53 has
widened a range of nuclear processes controlled by ly-
sine methylation (Chuikov et al., 2004).
Methylation of lysine residues within the conserved
N-terminal histone tail regulates transcriptional activity
(Kouzarides, 2002). Histone methylation is mediated by
methyltransferases (HMTases) that catalyze mono-, di-,
or tri-methylation of specific lysine residues (Bannister
et al., 2002). The functional significance of the HMTases
has been demonstrated by impaired embryonic devel-
opment and abnormal cell differentiation in mutant or-
ganisms from C. elegans to mice (Kouzarides, 2002).
The catalytic activity of the lysine-specific methyltrans-
ferases resides within the evolutionarily conserved SET
domain found in numerous chromatin regulators, ini-
tially defined by homology between three suppressors
of position effect of variegation (PEV): Su (var)3-9, En-
hancer of Zeste E (z), and Trithorax (Trx) (Tschiersch et
al., 1994).
Recently, we showed that conditional ablation of the
SET-domain-containing polycomb group protein Ezh2
in B lineage cells results in the selective loss of histone
H3 lysine 27 methylation (H3-K27) (Su et al., 2003). This
result and the specific methyltransferase activity of
purified Ezh2 protein (Cao et al., 2002; Czermin et al.,
2002; Kuzmichev et al., 2004; Kuzmichev et al., 2002;
Muller et al., 2002) support the selective and essential
role of Ezh2 in H3-K27 methylation. The histone-modi-
fying function of Ezh2 is consistent with its predomi-
nant nuclear localization in various cell types. However,
we found that fibroblast and peripheral T lymphocytes
also contain cytosolic Ezh2. This nonnuclear localiza-
tion of Ezh2 indicated a potential function for Ezh2 in
the cytosol.
Here we provide evidence for the existence of an
Ezh2-associated cytosolic methyltransferase protein
complex that controls cellular signaling via ligand-
induced actin polymerization in various cell types. Our
results suggest lysine methylation as a novel form of
posttranslational modification controlling not only nuclear,
but also proximal receptor-mediated signal transduc-
tion in mammalian cells. Defective T cell activation and
fibroblast proliferation in the absence of Ezh2 un-





ANonnuclear Localization of Ezh2
in Murine and Human Cells a
pIn ex vivo isolated thymocytes, the Ezh2 protein con-
centrated in the nucleus, while a fraction of Ezh2 was i
cpresent in the cytosol (Figure 1A). Compared to the thy-
mocytes, the expression level of nuclear Ezh2 was SFigure 1. Ezh2-Methyltransferase Complex in the Cytosol
(A–D) Cytosolic compartmentalization of Ezh2 in murine and human cells. Expression of Ezh2 in the nucleus and cytosol was analyzed in
thymocytes and purified lymph node T cells (A), Jurkat T cells (B), mouse embryonic fibroblasts (C) and HEK-293 cells (D). Lymph node T
cells were incubated in the absence or presence of plate bound anti-CD3 and soluble anti-CD28 antibodies for 48 hr. The Ezh2 protein in
nuclear or cytosolic cell extracts was detected by immunoblotting with anti-Ezh2 antibody. Expression of lamin B and tubulin was used to
control for the purity of the nuclear and cytosolic fractions, respectively. The asterisk indicates an unspecific band recognized by anti-Ezh2
antibody in murine cells.
(E) Cytosolic Ezh2 complex in HEK-293 cells. Control EGFP or Ezh2NLS/EGFP fusion proteins were transiently expressed in HEK-293 cells
and immunoprecipitated from the cytosolic lysates using an anti-GFP antibody. The presence of Ezh2, SUZ12, and EED in immunoprecipitates
was determined by immunoblotting with the corresponding antibodies.
(F) Methyltransferase activity of the cytosolic Ezh2 complex isolated from HEK-293 cells. The cytosolic Ezh2 complex was immunoprecipitated
using anti-GFP antibody. Three-fold dilutions of the Ezh2 complex were subjected to an in vitro methyltransferase assay using native nucleo-
some as substrate (upper panel). The amount of protein in the methyltransferase reactions was controlled by Coomassie blue staining (lower
panel). Position of the histones is indicated.
(G) Vav1 associates with the components of the cytosolic Ezh2 complex in Jurkat T cells. Jurkat T cells were stimulated with 1g/ml anti-
CD3 antibody (OKT3) for indicated periods of time. Vav1 was immunoprecipitated from cytosolic lysates of Jurkat cells using anti-Vav1
antibody. Normal rabbit IgG was used as a control for immunoprecipitation (rabbit IgG). The immunoprecipitates were analyzed for the
presence of EZH2, SUZ12, Vav1 and EED (upper panel) by Western blotting. Specificity of the EED antibody was confirmed by recognition of
a recombinant PRC3 complex (R.M. and D.R., unpublished data) containing purified EED protein (lower panel). Purity control of the cytosolic
fraction is shown in Figure S3.
(H) Methyltransferase activity of Vav1 containing cytosolic Ezh2 complex. Vav1-immunoprecipitates isolated from Jurkat T cells were used
for an in vitro methyltransferase assay using native nucleosome as a substrate.ower in peripheral T cells, while the amount of Ezh2
rotein in the cytosol remained the same (Figure 1A).
n additional protein that reacted with the anti-Ezh2
ntibody was present in the cytosol of thymocytes and
eripheral T cells. However, the presence of this protein
n cytosolic extracts derived from the Ezh2-deficient T
ells excluded it as an Ezh2 gene product (see Figure
1 in the Supplemental Data available with this article
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427online). The T cell antigen receptor (TCR)-mediated ac-
tivation of T cells led to an overall increase in Ezh2
mRNA (data not shown) and protein expression, which
was accompanied by an increase in the level of cyto-
solic Ezh2 (Figure 1A). Proliferating murine peripheral T
cells and human Jurkat T cells also contained signifi-
cant amounts of cytosolic Ezh2 (Figure 1B and data
not shown). The cytosolic localization of Ezh2 was not
unique to T lineage cells, as Ezh2 was present in the
cytosol of primary mouse embryonic fibroblasts (Figure
1C) and in the human embryonic kidney (HEK)-293 cells
(Figure 1D).
Cytosolic Ezh2 Forms Methyltransferase Complex
The presence of Ezh2 in the cytosol raises the question
of whether Ezh2 possesses methyltransferase activity
in the cytosol. In the nucleus, the histone-methyl-
transferase activity of Ezh2 depends on its association
with the proteins SUZ12 and EED (Cao and Zhang,
2004; Kuzmichev et al., 2004; Kuzmichev et al., 2002).
We found that similar to Ezh2, SUZ12 is present in the
cytosol of 293 cells (data not shown). The cytosolic lo-
calization of EED is reported previously (Witte et al.,
2004). To test whether cytosolic Ezh2 is associated with
the SUZ12 and EED, we used the HEK-293 cell line ex-
pressing Ezh2 lacking the nuclear localization signal
(Ezh2NLS). The Ezh2NLS protein, tagged with EGFP
localized predominantly, if not exclusively, in the cyto-
sol (Figure S2). Immunoprecipitation of the Ezh2NLS/
EGFP from the cytosolic lysate resulted in coprecipita-
tion of both SUZ12 and EED (Figure 1E). Furthermore, in-
cubation of the immunoprecipitated cytosolic Ezh2NLS/
EGFP complex with nucleosome, containing the known
Ezh2 substrate-histone H3, resulted in the dose-depen-
dent histone H3 methylation (Figure 1F). These results
demonstrate the ability of Ezh2 to form a functional
methyltransferase complex in the cytosol. Methylation
of the nucleosome substrate by the cytosolic Ezh2
should be seen primarily as an evidence for its enzy-
matic activity rather than reflection of the genuine Ezh2
substrate specificity in the cytosol. The nature of the
cytosolic Ezh2 substrate(s) remains unknown.
Endogenous Cytosolic EZH2 Complex
Associates with Vav1
The hypothetical site of action and hence the potential
substrate compartmentalization of the EZH2 was de-
duced from the previously reported association of
EZH2 and GTP/GDP exchange factor Vav1 (Hobert et
al., 1996). Indeed, immunoprecipitation of Vav1 from the
cytosol of Jurkat T cells coprecipitated EZH2 (Figure
1G). Moreover, SUZ12 (Figure 1G, left panel) was also
found in the Vav1 immunoprecipitates. The interaction
of Suz12 with Ezh2 and Vav1 was further confirmed
by anti-SUZ12 immunoprecipitation (data not shown).
Most importantly, incubation of Vav1 immunoprecipi-
tates with the nucleosome substrate resulted in histone
H3 methylation (Figure 1H). Neither the amounts of the
Vav1-associated EZH2 and SUZ12 nor the methyl-
transferase activity of the complex were affected by the
short-term TCR triggering (Figures 1G, left panel, and
1H). In contrast to SUZ12, that was abundant in the
cytosol of Jurkat T cells (Figures 1G, left panel, andS3), cytosolic EED was expressed at the level close to
detection limits (data not shown). Nonetheless, immu-
noprecipitation of Vav1 coprecipitated with EED (Figure
1G). Collectively, these experiments reveal the exis-
tence of a catalytically active EZH2 methyltransferase
complex in the cytosol of T lineage cells. The role of
Vav1 in the regulation of EZH2 activity or vice versa
remains to be understood. However, the association of
Vav1 with the methyltransferase complex comprised of
EZH2, EED, and SUZ12 suggests possible involvement
of EZH2-mediated methylation in signaling processes
controlled by Vav. One of the most well-characterized
Vav-dependent processes is the TCR-mediated actin
polymerization that through its general effect on vari-
ous signaling pathways contributes to T cell activation.
Ezh2 Is Essential for TCR-Induced
Actin Polymerization
The role of Ezh2 in TCR-mediated actin polymerization
was addressed using Ezh2-deficient peripheral T cells.
Ezh2-deficient T cells were derived from Ezh2fl/fl mice
expressing Cre recombinase under the control of CD4
minigene (CD4-Cre; Lee et al., 2001). Expression of
CD4-Cre led to deletion of the Ezh2 allele in double
positive (DP) thymocytes (data not shown). However,
deficiency of Ezh2 (Figure 2A) did not affect generation
of peripheral T cell compartment (Figure 2B and data
not shown). The Ezh2-deficient T cells appeared normal
as defined by expression of various differentiation and
activation markers including αβTCR-associated CD3,
coreceptors CD4 and CD8, and activation markers CD5
and CD69 (Figures 2B and 2C). Furthermore, despite
the loss of Ezh2, the global level of histone H3-K27
methylation in the Ezh2-deficient peripheral T cells re-
mained at the wild-type levels, as defined by immuno-
fluorescence staining (Figure 2D) and Western blotting
analysis of nuclear extracts (Figure S4). Lack of global
changes in H3-K27 methylation may explain the minor
effect of Ezh2 deficiency on gene expression (Figure
S5). Importantly, the expression of genes with known
relevance to signal transduction in T cells was not al-
tered.
Engagement of the TCR on Ezh2-deficient T cells
failed to induce actin polymerization (F-actin; Figure
3A). This defect was also evident in the recruitment of
F-actin to the interface of T cells and antigen-pre-
senting cells (APC). While deficiency in Ezh2 had no
obvious impact on the number of T cell-APC conju-
gates (Figure S6), actin polymerization and formation of
the actin ring structure at the T cell-APC interface, a
process known to be important for the maturation and
stability of the immunological synapse (IS; Cannon and
Burkhardt, 2002; Davis and Dustin, 2004; Dustin and Coo-
per, 2000; Fuller et al., 2003), was greatly impaired (Fig-
ure 3B).
Ezh2 Controls PDGF-Induced Actin
Polymerization in Fibroblasts
Triggering of the platelet-derived growth factor (PDGF)
receptor on wild-type fibroblasts leads to the formation
of actin-based structures known as membrane ruffles
(Ridley et al., 1992). Proteins involved in the formation
of the ruffles colocalize with this structure in PDGF-
Cell
428Figure 2. Ezh2 Is Not Required for Genera-
tion of Peripheral T Cells
(A–C) Ezh2-deficient T lineage cells in Ezh2fl/fl;
CD4-Cre mice.
(A) The amount of Ezh2 protein in splenic
and lymph node T cells isolated from control
and Ezh2fl/fl; CD4-Cre mice was analyzed by
immunoblotting using anti-Ezh2 antibody.
The amount of protein loaded was controlled
by the amount of actin.
(B) Frequencies of the CD4- and CD8-posi-
tive T cells in lymph nodes were analyzed
by FACS.
(C) Histograms show the expression levels of
indicated surface proteins in control (black
line) and Ezh2-deficient (red line) lymph node
T cells.
(D) Ezh2 does not control H3-K27 methyla-
tion in peripheral T cells. H3-27K methylation
in nuclei of Ezh2fl/fl and Ezh2fl/fl; CD4-Cre
lymph node T cells was revealed with anti-
body specific for tri-methyl H3-K27 (red). Nu-
clei were stained with DAPI (blue).treated fibroblasts (Lanzetti et al., 2004). The full-length a
mEzh2/EGFP fusion protein, while predominately localiz-
ing to the nuclei, was detected at low levels in the cell
Pperiphery and colocalized with polymerized F-actin
(Figures 4A and S7). In contrast to the Ezh2/EGFP, the e
texogenously expressed cytosolic Ezh2NLS/EGFP co-
localized almost exclusively with dorsal circular ruffles e
sin PDGF-treated fibroblasts (Figure 4A).
To further substantiate the role of cytosolic Ezh2 in f
ePDGF-induced actin polymerization, Ezh2-deficient mouse
embryonic fibroblasts (MEF) were analyzed. The en- E
tdogenous Ezh2 gene was inactivated by infection of
Ezh2fl/fl fibroblasts with Cre-expressing adenovirus (An- F
tton and Graham, 1995), which led to Ezh2 deficiency
within 48 hr (Figure S8A). Despite the loss of Ezh2, the i
cglobal levels of trimethylated H3-K27 remained similar
to those in nontransduced Ezh2fl/fl cells (Figure S8B). f
cThis result was consistent with the stability of histone
lysine methylation in Ezh2-deficient peripheral T cells d
m(Figure 2D). Maintenance of wild-type H3-K27 trimethyl-
ation levels argues against a potential nuclear-medi- ited indirect effect of Ezh2 deficiency on actin poly-
erization.
Incubation of the Ezh2-deficient fibroblasts with
DGF failed to induce dorsal circular ruffles (Figure 4B),
ven though expression of PDGF receptor β was similar
o wild-type cells (data not shown). Expression of exog-
nous full-length Ezh2 in Ezh2-deficient fibroblasts re-
tored PDGF-induced formation of dorsal circular ruf-
les (Figures 4C and 4D). A similar or more enhanced
ffect was observed in cells expressing a cytoplasmic
zh2 (Ezh2NLS; Figures 4C and 4D). The specific cy-
osolic localization of Ezh2NLS is shown in Figure S9.
urthermore, expression of Ezh2 with a mutation within
he SET domain that abolishes methyltransferase activ-
ty (Ezh2 H689A; Kuzmichev et al., 2002) failed to res-
ue the PDGF-induced formation of dorsal circular ruf-
les (Figures 4C and 4D). These data demonstrate that
ytosolic Ezh2 is sufficient to rescue the formation of
orsal circular ruffles in Ezh2-deficient MEFs and Ezh2
ethyltransferase activity is required for PDGF-induc-
ble actin polymerization in MEFs.
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429Figure 3. Ezh2 Controls TCR-Induced Actin Polymerization in Murine Lymph Node T Cells
(A) Histograms show the expression levels of polymerized actin (F-actin) in purified lymph node T cells isolated from Ezh2fl/fl, Ezh2fl/fl; CD4-
Cre, or Vav1−/− mice and incubated in the absence (filled area) or presence (solid line) of anti-CD3 antibody as described in the Experimen-
tal Procedures.
(B) Impaired actin polymerization at the T cell-APC interface. T cells isolated from control Ezh2fl/fl; DO11.10 Tg and experimental Ezh2fl/fl;
DO11.10 Tg; CD4-Cre mice were labeled with CFSE (green) and incubated with A20 cells preloaded with Ova323-339 peptide. Cell conjugates
were spun onto glass slides; the recruitment of F-actin at the T cell-APC interface was visualized by rhodamine-phalloidin staining (red) and
analyzed by confocal microscopy. Multiple Z stack images were acquired. One focal plane is shown in the upper panel. A profile view of the
3D reconstructed image is shown in the lower panel. Scale bar is equal to 5 m.Ezh2 Controls Actin Polymerization
Upstream of Cdc42
Polymerization of actin is a complex biochemical pro-
cess that is critically dependent on the activity of small
GTPases such as Cdc42 (Cox et al., 1997). Activation
of Cdc42 changes the conformation of Wiskott-Aldrich
syndrome protein (WASP) followed by activation of the
actin nucleation Arp2/3 complex and polymerization of
actin (Hall, 1998). In T cells, triggering of the TCR leads
to rapid activation of Cdc42 as determined by relative
increase of the GTP bound Cdc42 levels (Cannon and
Burkhardt, 2002). Wild-type and Ezh2-deficient T cells
expressed Cdc42 at similar levels (Figure 5A, lower
panel). In resting control or Ezh2-deficient T cells, the
active GTP bound form of Cdc42 was not detectable
(Figure 5A). Upon stimulation of the TCR, the amount
of active GTP-Cdc42 in control T cells increased con-
siderably, while only a small increase in Ezh2-deficientT cells was observed (Figure 5A). Moreover, 10 min after
stimulation, active GTP-Cdc42 was undetectable in the
mutant cells but remained relatively stable in control T
cells (Figure 5A).
Defective activation of Cdc42 in the absence of Ezh2
was not due to changes in TCR-mediated total protein
tyrosine phosphorylation (Figure S10A). The TCR-
induced tyrosine phosphorylation of key physiological
substrates such as ZAP70, LAT, Vav1, and PLCγ1
(Singer and Koretzky, 2002), the phosphorylation of
which precedes and is likely to control Cdc42 activation
(van Leeuwen and Samelson, 1999), was not affected
in Ezh2-deficient T cells (Figure S10B). Importantly,
phosphorylation of Vav1 on residue Tyr 174, which con-
trols its GTP/GDP exchange activity (Aghazadeh et al.,
2000) and is essential for Cdc42 activation (Acuto and
Cantrell, 2000; Krawczyk et al., 2000), was not affected
by the absence of Ezh2 (Figure S10B).
Cell
430Figure 4. Ezh2 Controls PDGF-Induced Actin Polymerization in Mouse Embryonic Fibroblasts
(A) Ezh2 colocalizes with the PDGF induced dorsal circular ruffles. MEFs were mock infected (control) or infected with the retroviruses
expressing EGFP (MIG), Ezh2/EGFP, or Ezh2NLS/EGFP fusion proteins. Control and transduced MEFs were starved in serum-free medium
for 24 hr followed by incubation with PDGF-BB (30 ng/ml) for 8 min. The cells were then fixed. Nuclei were identified by staining with DAPI
(blue); F-actin was visualized by rhodamine-phalloidin staining (red); EGFP, Ezh2/EGFP, and Ezh2NLS/EGFP fusion proteins were revealed
by anti-GFP (green). Three independent samples of cells expressing Ezh2NLS/EGFP are shown. Arrows indicate position of dorsal circular
ruffles. Scale bar is equal to 20 m.
(B) Defective dorsal circular ruffle formation in the absence of Ezh2. Serum-starved control and Ezh2-deficient MEFs were treated with PDGF-
BB for 8 min. The cells were fixed and F-actin was revealed by staining with phalloidin. Circular ruffles are indicated by arrows.
(C) Methyltransferase activity of Ezh2 controls PDGF-induced ruffle formation in MEFs. The Ezh2-deficient fibroblasts were transduced with
control virus (MIG) or viruses expressing the wild-type Ezh2, the cytosolic Ezh2 (Ezh2NLS) or enzymatically inactive Ezh2 (Ezh2H689A).
Transduced cells were starved in the absence of serum and stimulated with PDGF-BB. The circular ruffle formation (indicated by arrows) was
detected by phalloidin staining.
(D) Quantification of defective circular ruffle formation in the absence of Ezh2. Percentages of MEF, which displayed dorsal circular ruffles,
are shown. 3000–4000 control or virally-transduced cells were scored for each construct. MEFs expressing the constitutively active form of
Vav (onco-Vav) were used as a positive control for circular ruffle formation.
Ezh2 Controls TCR Signaling and Actin Polymerization
431Figure 5. Ezh2 Controls Actin Polymerization
Upstream of Cdc42
(A) Impaired Cdc42 activation in the absence
of Ezh2. Purified control or Ezh2-deficient T
cells were incubated in the absence or pres-
ence of anti-CD3 antibody for the indicated
periods of time. Active GTP bound Cdc42
was immunoprecipitated using GST-PAK-
PBD and resolved by SDS-PAGE. The amount
of Cdc42 potentially available for activation
was revealed by incubation of cell lysates
with nonhydrolyzable GTP analog (GTPγS).
The activated GTP bound and total cellular
Cdc42 were detected by Western blotting
using anti-Cdc42 antibody.
(B) Cell-permeable constitutively active Cdc42
restores actin polymerization in Ezh2-defi-
cient T cells. Control Ezh2fl/fl or Ezh2-defi-
cient purified lymph node T cells were incu-
bated in the absence (upper panel) or
presence (lower panel) of cell permeable tat-
V12-Cdc42 protein (200 nM) at 37°C for 30
min followed by stimulation with anti-CD3.
Histograms show F-actin levels in unstimu-
lated (filled area) or stimulated (solid line) T
cells.
(C) Constitutively active Cdc42, RAC1, and
oncogenic Vav rescue the dorsal circular ruf-
fle formation in Ezh2-deficient MEFs. Ezh2-
deficient MEFs were transduced with indi-
cated retroviral constructs or preloaded with
tat-V12-Cdc42. After 24 hr of serum starva-
tion, cells were stimulated with PDGF-BB
and dorsal circular ruffles (indicated by ar-
rows) were detected by phalloidin staining.If Ezh2 controls actin polymerization upstream of
Cdc42, then the expression of the constitutively active
form of Cdc42 in Ezh2-deficient cells should restore the
wild-type pattern of actin polymerization. To test this
model, we treated resting ex vivo isolated Ezh2-defi-
cient peripheral T cells with cell-permeable constitu-
tively active Cdc42 (tat-V12-Cdc42). The tat-V12-Cdc42
fusion protein was prepared and tested as described
previously (Nagahara et al., 1998; Soga et al., 2001).
Incubation of control and Ezh2-deficient T cells with
tat-V12-Cdc42 did not cause actin polymerization in the
absence of TCR engagement. However, upon anti-CD3
stimulation, tat-V12-Cdc42 restored actin polymeriza-
tion in Ezh2-deficient T cells to wild-type levels (Fig-
ure 5B).
Similar to the Ezh2-deficient T cells, treatment of the
Ezh2-deficient fibroblasts with cell-permeable Cdc42
restored PDGF-induced ruffle formation (Figure 5C).
Moreover, expression of the constitutively active form
of RAC1 or oncogenic Vav reconstituted the wild-type-
like actin polymerization in the Ezh2-deficient fibro-
blasts (Figure 5C). While the exact upstream and down-
stream partners of the Ezh2 in T cells and fibroblasts
remains unknown, our data suggest that cytosolic Ezh2
operates upstream of Cdc42 and Vav.
Ezh2 Controls Receptor-Mediated Cell Activation
Triggering of the TCR on Ezh2-deficient T cells resulted
in an impaired proliferative response (Figure 6A). The
defective Ezh2-deficient T cell proliferation was not
caused by reduced production of IL-2 or surface ex-pression of IL-2 receptor (data not shown). Costim-
ulation of T cells through CD28 or addition of exoge-
nous IL-2 increased proliferation of both wild-type and
Ezh2-deficient T cells (Figure 6A). Nonetheless, the re-
sponse of the mutant cells was greatly reduced (Figure
6A). The impaired TCR-induced T cell proliferation did
not reflect a general proliferative defect as Ezh2-defi-
cient and control T cells responded equally well to
phorbol myristate acetate (PMA) in combination with a
calcium ionophore (A23187; Figure 6A).
Similar to Ezh2-deficient T cells, the proliferative re-
sponses of the Ezh2-deficient fibroblasts to PDGF was
significantly reduced as compared to the wild-type
cells (Figure 6B). This defect was corrected by retroviral
expression of wild-type and cytosolic Ezh2, but not the
cytosolic methyltransferase inactive Ezh2NLSH689A
(Figure 6C). Notably, treatment of the Ezh2-deficient fi-
broblasts with serum, which contains a plethora of vari-
ous growth-promoting ligands operating via different
signaling pathways, induced proliferation at wild-type
levels (Figure 6B). This result highlights the specific role
of Ezh2 and its methyltransferase activity in regulation
of the PDGF-induced cell proliferation, but not cell divi-
sion in general.
Ezh2 Controls T Cell Differentiation in the Thymus
Impaired TCR-mediated actin polymerization and pro-
liferation in vitro suggested a role for Ezh2 in signaling
required for T cell development in the thymus. To ad-
dress this hypothesis, we studied the development of
thymocytes derived from the Ezh2-deficient bone mar-
Cell
432Figure 6. Ezh2 Controls TCR- or PDGF Re-
ceptor-Mediated Cell Proliferation
(A) Ezh2 controls TCR-mediated cell prolifer-
ation. Purified control (open bar) or Ezh2-
deficient (closed bar) lymph node T cells
were incubated for 48 hr in medium only
(medium) or in the presence of plate bound
anti-CD3 (10 g/ml) or anti-CD3 plus anti-
CD28 (5 g/ml, clone 37.51) with or without
recombinant IL-2 (40 ng/ml). Polyclonal cell
activation was triggered by PMA (10 ng/ml)
and ionophore A23187 (100 g/ml). Cell pro-
liferation was measured by [3H]-thymidine
uptake.
(B) Ezh2 controls PDGF-induced MEF prolif-
eration. Serum-starved control and Ezh2-
deficient MEFs were left in plain medium or
stimulated with PDGF-BB or serum. Cell pro-
liferation was measured by [3H]-thymidine
incorporation.
(C) The methyltransferase activity of Ezh2 is
essential for PDGF-induced MEF prolifera-
tion. The Ezh2-deficient MEFs were infected
with various retroviral constructs expressing
GFP (white bar), wild-type Ezh2/EGFP (black
bar), cytosolic Ezh2NLS/EGFP (gray bar),
or cytosolic catalytically inactive Ezh2NL-
SH689A/EGFP (light gray bar). The trans-
duced MEFs were starved, stimulated with
PDGF, and cell proliferation was measured
by [3H]-thymidine incorporation.
Each experiment was carried out in tripli-
cate, and error bars represent the standard
deviation.row stem cells. Inactivation of the Ezh2 gene in the e
abone marrow of Ezh2fl/fl; Mx-Cre mice (Ku¨hn et al.,
1995) was achieved by poIy(I)•poly(C)-inducible Cre ex- E
ypression. Ezh2 deletion was confirmed by Southern
blot analysis as described previously (Su et al., 2003). m
Ezh2-deficient marrow cells were transferred into le-
thally irradiated C57BL/6 mice. Transfer of bone mar- E
drow cells from control poly(I)•poly(C)-treated Ezh2fl/fl
mice produced thymi containing all developmental sub- p
tpopulations at expected frequencies and numbers (Fig-
ure 7A). Transfer of Ezh2-deficient bone marrow cells c
iinto irradiated recipients failed to support normal thy-
mocyte development (Figure 7A). Thymi of mice, which v
areceived Ezh2-deficient bone marrow, contained 10 to
100 times fewer cells than their control counterparts s
g(data not shown). Development of Ezh2-deficient thy-
mocytes was arrested at the early CD4, CD8 double c
(negative (DN) CD44intCD25hi stage (Figure 7A); conse-
quently, almost no mature T cells were present in the l
iperiphery (Figure 7B). The failure of Ezh2-deficient DN
cells to develop into mature thymocytes within the o
HEzh2-positive recipient microenvironment suggests
that lack of Ezh2 causes a cell-autonomous defect of T t
1lineage cells.
Trimethylated H3-K27 was completely abolished in b
rthe Ezh2-deficient DN cells (Figure S11). Similar defects
in early B cell progenitors is associated with defective t
sV(D)J rearrangement of the immunoglobulin heavy
chain gene Igh locus (Su et al., 2003). In contrast to tarly B cell progenitors, the rearrangement of the TCRb
s well as Vg genes in DN cells was not affected by
zh2 deficiency (Figure S12). The lack of H3-K27 meth-
lation may affect thymocyte development through the
echanisms other than the TCR gene rearrangement.
In view of defective TCR signaling in the absence of
zh2, it is plausible that developmental arrest of Ezh2-
eficient thymocytes could also be caused by impaired
re-TCR signaling. Several lines of evidence support
he signaling role for Ezh2 in pre-TCR-mediated thymo-
yte development. In the absence of a signaling defect,
.e., in rearrangement-deficient RAG1−/− mice, the de-
elopmental block could be overcome by expression of
transgenic TCR (Shinkai et al., 1993). However, expres-
ion of either MHC class I- or class II-restricted trans-
enic TCR (HY or DO11.10, respectively) in Ezh2-defi-
ient T lineage cells did not restore their development
Figure 7C). In these experiments, the Cre-mediated de-
etion of the Ezh2 gene was induced by poly(I)•poly(C)
njection into female TCR transgenic Ezh2fl/fl, Mx-Cre,
r Ezh2fl/fl control mice. Ezh2 deficiency arrested both
Y and DO11.10 transgenic TCR-expressing cells at
he DN stage, as indicated by the absence of DP cells
0 days after poly(I)•poly(C) injection (Figure 7C). The
lock in T cell development was complete, since the
emaining CD4 or CD8 single-positive thymocytes showed
he Ezh2fl/fl genotype (data not shown) and likely repre-
ent a fraction of cells that failed to delete Ezh2 in the
hymus.
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(A) Ezh2 controls T cell differentiation in the thymus. Ly9.1+ Ezh2-deficient bone marrow cells were transferred into lethally irradiated C57BL/6
mice. Ten weeks after transplantation, T cell development was analyzed by FACS using antibodies against CD4, CD8 (upper panel), CD44,
and CD25 (lower panel). Numbers show the percentage of gated cells.
(B) Expression of CD4 and CD8 in control and Ezh2-deficient peripheral T cells.
(C) Expression of transgenic TCR fails to support the development of Ezh2-deficient T cells. Thymocytes derived from poly(I)•poly(C)-treated
control Ezh2fl/fl or experimental Ezh2fl/fl; Mx-Cre mice with indicated TCR transgene were analyzed by FACS 10 days after the treatment.
(D) Ezh2 controls anti-CD3-induced differentiation of DN into DP cells. Poly(I)•poly(C)-treated Ezh2f/f; RAG1−/− and Ezh2f/f; Mx-Cre; RAG1−/−
mice were injected with 100 g of anti-CD3 antibody (145-2C11). Expression of CD44 and CD25 was analyzed by FACS at indicated time
points after injection.Furthermore, defective signaling in the absence of
Ezh2 was confirmed by failure of the Ezh2-deficient DN
cells to progress to DP cells in response to anti-CD3
stimulation in vivo (Figure 7D). Injection of anti-CD3 an-
tibody into RAG1-deficient mice causes differentiation
of CD25hiCD44- thymocytes into CD25lowCD44− cells,
followed by their proliferative expansion and generation
of DP cells (Jacobs et al., 1994; Shinkai and Alt, 1994).
This developmental progression did not happen in the
absence of Ezh2 (Figure 7D). Notably, the observed sig-
naling defect does not reflect a general proliferative
impairment of Ezh2-deficient DN cells, as they divided
vigorously in vitro in response to IL-7 and PMA (Fig-
ure S13).Discussion
Ablation of Ezh2 leads to defective PDGF- and TCR-
induced actin polymerization in fibroblasts and T cells,
respectively. Several lines of evidence suggest that this
novel role of Ezh2 in cell signaling is mediated by cyto-
solic Ezh2 in a methyltransferase-dependent fashion.
First, rescue of receptor-induced actin polymerization
in Ezh2-deficient fibroblasts by cytosolic Ezh2 indi-
cates a direct role for cytosolic Ezh2 in actin polymer-
ization. Furthermore, failure of enzymatically inactive
Ezh2 to rescue actin polymerization points to an essen-
tial role of Ezh2 methyltransferase activity in the regula-
tion of this process.
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involvement in actin polymerization comes from the ob- a
servation that wild-type levels of global histone H3-K27 o
methylation exist in Ezh2-deficient T cells. One pos- p
sible explanation for the apparent normal level of H3- t
K27 methylation may lie in the stability of the methyl t
mark placed by Ezh2 at early stages of T cell develop- E
ment before CD4-Cre-mediated Ezh2 gene inactivation.
The unaltered global levels of histone H3-K27 methyla- t
tion may explain the lack of significant changes in the p
pattern and overall level of gene expression, including n
genes that encode various signaling proteins in Ezh2- c
deficient T cells. T
The genetic evidence for the direct role of Ezh2 in v
regulating actin polymerization is further substantiated E
by the identification of a cytosolic Ezh2 methyltransfer- d
ase complex. We found the Polycomb protein Ezh2 in e
an enzymatically active complex with Eed and Suz12 in m
the cytosol of murine and human cells, which structur- s
ally resembles the Ezh2 nuclear complex. In addition to m
the previously characterized nuclear complex, the cyto- b
solic Ezh2 complex in Jurkat cells contained Vav1. As S
fibroblasts do not express Vav1 (Bustelo, 2000), the cy- f
tosolic complex in these cells may contain Vav2 and/or m
Vav3, as they posses the conserved N-terminal domain i
responsible for Ezh2-Vav1 interaction (Bustelo, 2000; d
Hobert et al., 1996). Association with Vav may explain c
the observed localization of Ezh2 at the site of actin b
polymerization. In fibroblasts, cytosolic Ezh2 colocal-
izes with the actin-rich dorsal ruffles at the cell surface. e
It is likely that interaction between Ezh2 and Eed also t
occurs at the plasma membrane since Eed localization d
to the plasma membrane has been reported previously E
(Witte et al., 2004). t
In T cells and fibroblasts, ligand-induced actin poly- e
merization depends on receptor-mediated protein tyro- a
sine phosphorylation, which leads to the activation of
various small GTPases that control actin polymerization t
through regulation of WASP and WASP-related proteins v
(Hall, 1998). Interaction with Vav positions Ezh2 proxi- a
mal to the small GTPases that control actin polymeriza- a
tion (Hall, 1998). Indeed, the reduced amount of acti- m
vated Cdc42 in TCR-triggered Ezh2-deficient T cells t
suggests that Ezh2 regulates signaling events between
r
TCR and Cdc42. Wild-type like actin polymerization in
Ezh2-deficient T cells and fibroblasts expressing con- E
stitutively active Rac1 and Cdc42 argues in favor of
Ezh2 operating upstream of small GTPases and con- E
Ftrolling signals generated between the surface ex-
fpressed receptor and small GTPases.
vThe exact mechanism of the Ezh2 involvement in reg-
Mulation of Cdc42 and hence actin polymerization re-
c
mains unknown. The possibility that Ezh2 controls the d
GTP/GDP exchange activity of Vav1 through lysine B
methylation is unlikely, as we could not detect lysine P
cmethylation of Vav1 (data not shown). Ezh2 is also un-
rlikely to control the phosphorylation of Vav1 since the
total level of Vav1 phosphorylation and the phosphory-
Flation of tyrosine residue 174 on Vav1 were not affected
Tby the absence of Ezh2. As tyrosine 174 controls Vav1
l
GTP/GDP exchange activity (Aghazadeh et al., 2000) (
and is essential for Cdc42 activation (Acuto and 5
Cantrell, 2000; Krawczyk et al., 2000), this suggests C
PEzh2 does not regulate Vav1 activity. It is possible thatzh2 exerts its function through methylation of Vav1-
ssociated proteins that contribute to the activity and/
r assembly of the receptor-associated signaling com-
lex. Indeed, we found several Vav1-associated pro-
eins are methylated during a methyltransferase reac-
ion in vitro. Functional connection of these proteins to
zh2 is currently under investigation.
The role of Ezh2 in actin polymerization bears impor-
ant functional implications. Ezh2 deficiency renders
eripheral T cells poorly responsive to proliferative sig-
als induced by TCR. Hence Ezh2 is likely to control T
ell responses to antigenic stimulation in vivo. Impaired
CR signaling may also contribute to the arrested de-
elopment of Ezh2-deficient thymocytes. Ablation of
zh2 in early thymocyte progenitors prevents T cell
evelopment even in the presence of the surface-
xpressed and hence potentially functional TCR. The
agnitude of observed developmental defect in the ab-
ence of Ezh2 is similar to the greatly impaired develop-
ent of thymocytes deficient for all three known mem-
ers of the Vav family proteins (Fujikawa et al., 2003).
hould Vav2 and Vav3 interact with Ezh2, then the de-
ective development in the absence of Vav1, 2, and 3
ay result from the impaired Ezh2 signaling. However,
t cannot be excluded that in addition to the signaling
efects, the development of Ezh2-deficient DN thymo-
ytes is also affected by epigenetic changes imposed
y the lack of H3-K27 methylation.
Poor PDGF-induced actin polymerization and prolif-
ration in Ezh2-deficient fibroblasts indicates an impor-
ant role for Ezh2 in stromal cell growth. In view of our
ata, it is conceivable that increased expression of
zh2 in prostate and breast cancer cells contributes to
heir metastatic capacity (Kleer et al., 2003; Kuzmichev
t al., 2005; Varambally et al., 2002) via regulation of
ctin-dependent cell adhesion and migration.
In conclusion, we have identified a cytosolic methyl-
ransferase Ezh2-containing complex and have pro-
ided evidences for its importance in ligand-induced
ctin polymerization. We would like to propose that in
ddition to controlling gene activity through histone
ethylation, Ezh2 may control gene function via regula-
ion of nuclear actin that is associated with chromatin
emodeling complexes (Bettinger et al., 2004).
xperimental Procedures
xpression Vectors
ull-length Ezh2 cDNA excised from the pBS-N8.14 plasmid (a gift
rom Dr. O. Hobert) was subcloned into the mammalian expression
ector pEGFP (BD Clontech) and the retroviral expression vectors
IG-IRES-GFP and MIG. Deletion of the NLS sequence from Ezh2
DNA and exchange of the histidine at position 689 within the SET
omain to alanine (Ezh2 H689A) was performed using ExSite PCR-
ased Site-Directed Mutagenesis Kit from Stratagene (California).
lasmids containing oncogenic Vav and constitutively active RAC1
DNAs were kindly provided by Dr. A. Weiss and Dr. X. Bustelo,
espectively.
ACS Analysis and Cell Culture
he preparation of ex-vivo isolated cells for FACS analysis, CFSE
abeling, and cell culture was performed as previously described
Su et al., 2003). PMA and A23187 were obtained from Calbiochem.
(and 6-)-carboxyfluorescein diacetate, succinimidyl ester (5(6)-
FDA-SE) used for CFSE labeling was purchased from Molecular
robes.
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435MEFs were prepared from day E14.5 Ezh2fl/fl embryos. The
Ezh2fl/fl allele was deleted in vitro by infection with Adeno-Cre virus.
Twenty-four hours after infection, the MEFs were serum starved for
24 hr and then stimulated with 30 ng/ml of PDGF-BB (Upstate).
F-actin staining was performed as described below.
Thymidine Incorporation Assay
Cell proliferation was determined by incorporation of [3H]-thymi-
dine into DNA as described previously (Tarakhovsky et al., 1995).
In brief, 2 × 105 purified T cells were seeded in 96-well tissue cul-
ture plates, stimulated with various stimuli for 48 hr, and pulsed
with [3H]-thymidine (1 Ci/well; Amersham Pharmacia Biotech) for
the final 8 hr. 8 × 103 MEFs were plated in 96-well tissue culture
plates. Twelve hours later, cells were starved in serum-free medium
for the next 24 hr. One Ci of [3H]-thymidine with or without PDGF-
BB in plain or serum-containing medium was added to the wells.
Cells were harvested after 12 hr of labeling. Proliferation of the cells
was measured by radiometric analysis in counts per minute (cpm).
All samples were run in triplicates.
Actin Polymerization and Immunofluorescence Microscopy
Purified T cells were incubated on ice with anti-CD3 (145-2C11, 20
g/ml) for 30 min and then crosslinked at 37°C with goat anti-ham-
ster antibody (40 g/ml; Jackson ImmunoResearch) for 30 min. The
cells were fixed in 2.5% paraformaldehyde, permeabilized in 0.1%
Triton X-100/PBS on ice for 5 min, and F-actin was stained by FITC-
or rhodamine-phalloidin (Molecular Probes). The actin content was
analyzed by FACS. Images were collected using either a wide-field
fluorescence microscope or a confocal microscope (LSM 510
microscope; Zeiss, Jena, Germany).
Biochemical Assays
Immunoprecipitation and immunoblotting were performed accord-
ing to standard procedures. Rabbit anti-Ezh2 and anti-Vav1 anti-
bodies were purchased from Upstate. Activated Cdc42 was de-
tected using the EZ-detect Cdc42 Activation Kit (Pierce). Agarose
beads conjugated to anti-Vav1, anti-phosphotyrosine (clone PY99)
and goat anti-Ezh2 antibody were purchased from Santa Cruz.
Anti-Suz12 antibody was acquired from Abcam. Anti-Eed (M26) an-
tibody was a gift from Dr. Otte.
Methyltransferase Assay
Methyltransferase assays were performed essentially as described
(Kuzmichev et al., 2004). In brief, the anti-GFP or Vav1 immuno-
precipitates were incubated at 30°C for 45 min, with native nucleo-
some in a buffer containing 50 mM Tris-HCl (pH 8.5), 5 mM MgCl2,
4 mM DTT, and 1 M [3H]-labeled S-adenosyl methionine (Amersham
Pharmacia Biotech). Reactions were stopped by adding SDS-PAGE
sample buffer, and the reaction products were separated on a two-
step gradient SDS (8% and 16.5%) polyacrylamide gel. The gel was
stained with Coomassie blue and incubated with EN3HANCE (NEN)
solution according to the manufacturer’s instruction. The gel was
then dried and autoradiographed. Purification of recombinant poly-
comb repressive complex 3 (rPRC3) and native nucleosome were
done as described previously (Kuzmichev et al., 2002).
Supplemental Data
Supplemental Data include thirteen figures and Supplemental Ex-
perimental Procedures and can be found with this article online at
http://www.cell.com/cgi/content/full/121/3/425/DC1/.
Acknowledgments
We thank L. Donlin, E. Besmer, S. Sahota, and I. Mecklenbräuker
for critical reading of this manuscript and T. Jenuwein for discus-
sion. We also thank J. Zhao for data processing and statistical
analysis of GeneChip data. This work was supported by The Irene
Diamond Fund/Professorship Program (A.T.), National Institutes of
Health Grants 5-RO1-AI050867 and 5-RO1-AI053545 (A.T. and I.S.).
It was supported in part by The Cancer Research Institute Predoc-
toral Emphasis Pathway in Tumor Immunology (M.-W.D.).Received: September 4, 2004
Revised: January 1, 2005
Accepted: February 22, 2005
Published: May 5, 2005
References
Acuto, O., and Cantrell, D. (2000). T cell activation and the cytoskel-
eton. Annu. Rev. Immunol. 18, 165–184.
Aghazadeh, B., Lowry, W.E., Huang, X.Y., and Rosen, M.K. (2000).
Structural basis for relief of autoinhibition of the Dbl homology do-
main of proto-oncogene Vav by tyrosine phosphorylation. Cell 102,
625–633.
Anton, M., and Graham, F.L. (1995). Site-specific recombination
mediated by an adenovirus vector expressing the Cre recombinase
protein: a molecular switch for control of gene expression. J. Virol.
69, 4600–4606.
Bannister, A.J., Schneider, R., and Kouzarides, T. (2002). Histone
methylation: Dynamic or static? Cell 109, 801–806.
Bettinger, B.T., Gilbert, D.M., and Amberg, D.C. (2004). Actin up in
the nucleus. Nat. Rev. Mol. Cell Biol. 5, 410–415.
Bustelo, X.R. (2000). Regulatory and signaling properties of the Vav
family. Mol. Cell. Biol. 20, 1461–1477.
Cannon, J.L., and Burkhardt, J.K. (2002). The regulation of actin
remodeling during T-cell-APC conjugate formation. Immunol. Rev.
186, 90–99.
Cao, R., and Zhang, Y. (2004). SUZ12 is required for both the his-
tone methyltransferase activity and the silencing function of the
EED-EZH2 complex. Mol. Cell 15, 57–67.
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H.,
Tempst, P., Jones, R.S., and Zhang, Y. (2002). Role of histone H3
lysine 27 methylation in Polycomb-group silencing. Science 298,
1039–1043.
Cheung, P., Allis, C.D., and Sassone-Corsi, P. (2000). Signaling to
chromatin through histone modifications. Cell 103, 263–271.
Chuikov, S., Kurash, J.K., Wilson, J.R., Xiao, B., Justin, N., Ivanov,
G.S., McKinney, K., Tempst, P., Prives, C., Gamblin, S.J., et al.
(2004). Regulation of p53 activity through lysine methylation. Na-
ture 432, 353–360.
Cox, D., Chang, P., Zhang, Q., Reddy, P.G., Bokoch, G.M., and
Greenberg, S. (1997). Requirements for both Rac1 and Cdc42 in
membrane ruffling and phagocytosis in leukocytes. J. Exp. Med.
186, 1487–1494.
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., and Pirrotta,
V. (2002). Drosophila enhancer of Zeste/ESC complexes have a his-
tone H3 methyltransferase activity that marks chromosomal poly-
comb sites. Cell 111, 185–196.
Davis, D.M., and Dustin, M.L. (2004). What is the importance of the
immunological synapse? Trends Immunol. 25, 323–327.
Downward, J. (2001). The ins and outs of signalling. Nature 411,
759–762.
Dustin, M.L., and Cooper, J.A. (2000). The immunological synapse
and the actin cytoskeleton: molecular hardware for T cell signaling.
Nat. Immunol. 1, 23–29.
Fujikawa, K., Miletic, A.V., Alt, F.W., Faccio, R., Brown, T., Hoog, J.,
Fredericks, J., Nishi, S., Mildiner, S., Moores, S.L., et al. (2003).
Vav1/2/3-null mice define an essential role for Vav family proteins
in lymphocyte development and activation but a differential
requirement in MAPK signaling in T and B cells. J. Exp. Med. 198,
1595–1608.
Fuller, C.L., Braciale, V.L., and Samelson, L.E. (2003). All roads lead
to actin: the intimate relationship between TCR signaling and the
cytoskeleton. Immunol. Rev. 191, 220–236.
Hall, A. (1998). Rho GTPases and the actin cytoskeleton. Science
279, 509–514.
Hobert, O., Jallal, B., and Ullrich, A. (1996). Interaction of Vav with
ENX-1, a putative transcriptional regulator of homeobox gene ex-
pression. Mol. Cell. Biol. 16, 3066–3073.
Jacobs, H., Vandeputte, D., Tolkamp, L., de Vries, E., Borst, J., and
Cell
436Berns, A. (1994). CD3 components at the surface of pro-T cells D
Gcan mediate pre-T cell development in vivo. Eur. J. Immunol. 24,
934–939. C
SKane, L.P., Lin, J., and Weiss, A. (2000). Signal transduction by the
TCR for antigen. Curr. Opin. Immunol. 12, 242–249. C
oKleer, C.G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S.A.,
NGhosh, D., Sewalt, R.G., Otte, A.P., Hayes, D.F., et al. (2003). EZH2
is a marker of aggressive breast cancer and promotes neoplastic T
jtransformation of breast epithelial cells. Proc. Natl. Acad. Sci. USA
100, 11606–11611. m
tKouzarides, T. (2002). Histone methylation in transcriptional control.
Curr. Opin. Genet. Dev. 12, 198–209. T
RKrawczyk, C., Bachmaier, K., Sasaki, T., Jones, G.R., Snapper, B.S.,
eBouchard, D., Kozieradzki, I., Ohashi, S.P., Alt, W.F., and Penninger,
oM.J. (2000). Cbl-b is a negative regulator of receptor clustering and
1raft aggregation in T cells. Immunity 13, 463–473.
vKu¨hn, R., Schwenk, F., Aguet, M., and Rajewsky, K. (1995). Induc-
tible gene targeting in mice. Science 269, 1427–1429.
VKuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P.,
mand Reinberg, D. (2002). Histone methyltransferase activity associ-
Oated with a human multiprotein complex containing the Enhancer
vof Zeste protein. Genes Dev. 16, 2893–2905.
WKuzmichev, A., Jenuwein, T., Tempst, P., and Reinberg, D. (2004).
SDifferent EZH2-containing complexes target methylation of histone
mH1 or nucleosomal histone H3. Mol. Cell 14, 183–193.
pKuzmichev, A., Margueron, R., Vaquero, A., Preissner, T.S., Scher,
M., Kirmizis, A., Ouyang, X., Brockdorff, N., Abate-Shen, C., Farn-
ham, P., and Reinberg, D. (2005). Composition and histone sub-
strates of polycomb repressive group complexes change during
cellular differentiation. Proc. Natl. Acad. Sci. USA 102, 1859–1864.
Lachner, M., and Jenuwein, T. (2002). The many faces of histone
lysine methylation. Curr. Opin. Cell Biol. 14, 286–298.
Lanzetti, L., Palamidessi, A., Areces, L., Scita, G., and Di Fiore, P.P.
(2004). Rab5 is a signalling GTPase involved in actin remodelling
by receptor tyrosine kinases. Nature 429, 309–314.
Lee, P.P., Fitzpatrick, D.R., Beard, C., Jessup, H.K., Lehar, S., Makar,
K.W., Perez-Melgosa, M., Sweetser, M.T., Schlissel, M.S., Nguyen,
S., et al. (2001). A critical role for Dnmt1 and DNA methylation in T
cell development, function, and survival. Immunity 15, 763–774.
McBride, A.E., and Silver, P.A. (2001). State of the arg: Protein meth-
ylation at arginine comes of age. Cell 106, 5–8.
Muller, J., Hart, C.M., Francis, N.J., Vargas, M.L., Sengupta, A.,
Wild, B., Miller, E.L., O’Connor, M.B., Kingston, R.E., and Simon,
J.A. (2002). Histone methyltransferase activity of a Drosophila poly-
comb group repressor complex. Cell 111, 197–208.
Nagahara, H., Vocero-Akbani, A.M., Snyder, E.L., Ho, A., Latham,
D.G., Lissy, N.A., Becker-Hapak, M., Ezhevsky, S.A., and Dowdy,
S.F. (1998). Transduction of full-length TAT fusion proteins into
mammalian cells: TAT-p27Kip1 induces cell migration. Nat. Med. 4,
1449–1452.
Pawson, T. (2004). Specificity in signal transduction: From phos-
photyrosine-SH2 domain interactions to complex cellular systems.
Cell 116, 191–203.
Ridley, A.J., Paterson, H.F., Johnston, C.L., Diekmann, D., and Hall,
A. (1992). The small GTP-binding protein rac regulates growth
factor-induced membrane ruffling. Cell 70, 401–410.
Schreiber, S.L., and Bernstein, B.E. (2002). Signaling network
model of chromatin. Cell 111, 771–778.
Shinkai, Y., and Alt, F.W. (1994). CD3 epsilon-mediated signals res-
cue the development of CD4+CD8+ thymocytes in RAG-2−/− mice
in the absence of TCR beta chain expression. Int. Immunol. 6,
995–1001.
Shinkai, Y., Koyasu, S., Nakayama, K., Murphy, K.M., Loh, D.Y.,
Reinherz, E.L., and Alt, F.W. (1993). Restoration of T cell develop-
ment in RAG-2-deficient mice by functional TCR transgenes. Sci-
ence 259, 822–825.
Singer, A.L., and Koretzky, G.A. (2002). Control of T cell function by
positive and negative regulators. Science 296, 1639–1640.
Soga, N., Namba, N., McAllister, S., Cornelius, L., Teitelbaum, S.L.,owdy, S.F., Kawamura, J., and Hruska, K.A. (2001). Rho family
TPases regulate VEGF-stimulated endothelial cell motility. Exp.
ell Res. 269, 73–87.
u, I.H., Basavaraj, A., Krutchinsky, A.N., Hobert, O., Ullrich, A.,
hait, B.T., and Tarakhovsky, A. (2003). Ezh2 controls B cell devel-
pment through histone H3 methylation and Igh rearrangement.
at. Immunol. 4, 124–131.
arakhovsky, A., Turner, M., Schaal, S., Mee, P.J., Duddy, L.P., Ra-
ewsky, K., and Tybulewicz, V.L. (1995). Defective antigen receptor-
ediated proliferation of B and T cells in the absence of Vav. Na-
ure 374, 467–470.
schiersch, B., Hofmann, A., Krauss, V., Dorn, R., Korge, G., and
euter, G. (1994). The protein encoded by the Drosophila position-
ffect variegation suppressor gene Su(var)3–9 combines domains
f antagonistic regulators of homeotic gene complexes. EMBO J.
3, 3822–3831.
an Leeuwen, J.E., and Samelson, L.E. (1999). T cell antigen-recep-
or signal transduction. Curr. Opin. Immunol. 11, 242–248.
arambally, S., Dhanasekaran, S.M., Zhou, M., Barrette, T.R., Ku-
ar-Sinha, C., Sanda, M.G., Ghosh, D., Pienta, K.J., Sewalt, R.G.,
tte, A.P., et al. (2002). The polycomb group protein EZH2 is in-
olved in progression of prostate cancer. Nature 419, 624–629.
itte, V., Laffert, B., Rosorius, O., Lischka, P., Blume, K., Galler, G.,
tilper, A., Willbold, D., D’Aloja, P., Sixt, M., et al. (2004). HIV-1 Nef
imics an integrin receptor signal that recruits the polycomb group
rotein Eed to the plasma membrane. Mol. Cell 13, 179–190.
